BioInfra Co., Ltd. (KOSDAQ:199730)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,835.00
-120.00 (-2.42%)
At close: Jan 19, 2026

BioInfra Revenue

BioInfra had revenue of 5.07B KRW in the quarter ending September 30, 2025, a decrease of -33.50%. This brings the company's revenue in the last twelve months to 21.92B, down -16.15% year-over-year. In the year 2024, BioInfra had annual revenue of 23.83B, down -20.90%.

Revenue (ttm)
21.92B
Revenue Growth
-16.15%
P/S Ratio
1.06
Revenue / Employee
n/a
Employees
n/a
Market Cap
23.20B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202423.83B-6.30B-20.90%
Dec 31, 202330.13B-5.30B-14.96%
Dec 31, 202235.43B4.87B15.94%
Dec 31, 202130.56B10.95B55.82%
Dec 31, 202019.61B2.32B13.42%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
LabGenomics89.36B
HLB bioStep71.47B
C&R Research63.97B
DreamCIS62.06B
DT&CRO CO.44.36B
WOOJUNG BIO37.12B
P&K Skin Research Center22.13B
Curachem6.02B
Revenue Rankings